Pharmaceutical actuation in intensive care units: contributions to rational use of drugs
DOI:
https://doi.org/10.30968/rbfhss.2019.104.0429Abstract
Objective: Evaluate the performance of the clinical pharmacist in Adult Intensive Care Units of a special-sized hospital, wherein pharmacotherapeutic follow-up is the main activity developed by the pharmacist residing in intensive care. Methods: This is an observational, cross-sectional study with a quantitative approach, carried out in Adult Intensive Care Units, from March to June 2018. Data were collected from the Clinical Pharmacy Service, by means of already established indicators. Results: During the study period, 958 patients were admitted and 664 were included in the study. Regarding the place of hospitalization, 57% of the patients included in the study were hospitalized in the Post-operative Intensive Care Unit and 43% in the Clinical Intensive Care Unit. The suggested interventions were well accepted (99.6%), and in the clinical intensive care unit, the number of interventions performed and the cost saving were higher in all months of the study. The main interventions were drugs inclusion / withdrawal, dose reduction, infusion time and dilution. Of the interventions accepted, 25% generated cost savings, saving R $ 163,656.40 in total, and the types of interventions related to the most frequent cost saving were withdrawal of the drug (58.5%), dose reduction (32.6%) and change of pharmaceutical formula (3.0%). Conclusion: The performance of the clinical pharmacist in intensive care units was well accepted by the medical team. The various possibilities of interventions contribute to rational use of drugs and, in addition, some of these pharmaceutical interventions have a direct impact on cost savings.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 RBFHSS and the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
